Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug could ease painful muscle condition and cut steroid use

NCT ID NCT07670546

Ongoing Disease control Sponsor: R-Pharm International, LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This phase 3 trial tests a biologic drug called olokizumab in 125 people with polymyalgia rheumatica, a condition causing muscle pain and stiffness. The drug is given as a shot every two weeks. The main goal is to see if it can control symptoms and allow patients to take lower doses of steroids. The study is active but not recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Olokizumab (a biologic drug given as a shot under the skin)
What this could lead to
If it works, this could offer a new treatment option for polymyalgia rheumatica that helps reduce the need for steroids.
What could go wrong
This is a phase 3 trial, but it is still relatively small (125 people). The drug may not prove effective or could have side effects. It is not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYMYALGIA RHEUMATICA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polymyalgia rheumatica

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POLYMYALGIA RHEUMATICA

Contacts and locations

Locations

  • A.S. Loginov Moscow Clinical Scientific Center

    Moscow, 111123, Russia

  • Academician I.P. Pavlov Ryazan State Medical University

    Ryazan, 390026, Russia

  • Biomed LLC

    Vladimir, 600005, Russia

  • Center for Medical Consultations and Research - PRAKTIKA LLC

    Yaroslavl, 150054, Russia

  • Family Polyclinic No. 4 LLC

    Korolyov, 141060, Russia

  • Healthy Family Medical Center LLC

    Novosibirsk, 630099, Russia

  • I.M. Sechenov First Moscow State Medical University, Center for Clinical Studies of Medicinal Products

    Moscow, 119435, Russia

  • Interleukin LLC

    Saint Petersburg, 194214, Russia

  • M.F. Vladimirsky Moscow Regional Research and Clinical Institute (MONIKI)

    Moscow, 129110, Russia

  • Medical and Sanitary Unit No. 157 LLC

    Saint Petersburg, 196066, Russia

  • N.A. Semashko Nizhny Novgorod Regional Clinical Hospital

    Nizhny Novgorod, 603126, Russia

  • Omsk Regional Clinical Hospital

    Omsk, 644012, Russia

  • Research Institute of Clinical and Experimental Lymphology - Branch of the Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences

    Novosibirsk, 630117, Russia

  • Russian Gerontology Research and Clinical Center, Pirogov Russian National Research Medical University

    Moscow, 129226, Russia

  • Siberian State Medical University, Ministry of Health of the Russian Federation

    Tomsk, 634050, Russia

  • Smolensk Regional Rheumatology Center at the Clinical Hospital "RZD-Medicine" of the City of Smolensk (Private Healthcare Institution)

    Smolensk, 214025, Russia

  • State Budgetary Healthcare Institution Republican Clinical Hospital named after G.G. Kuvatov

    Ufa, 450005, Russia

  • Udmurt Republic Clinical and Diagnostic Center, Ministry of Health of the Udmurt Republic

    Izhevsk, 426009, Russia

  • V.A. Nasonova Research Institute of Rheumatology

    Moscow, 115522, Russia

  • Yaroslavl Central City Hospital

    Yaroslavl, 150047, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.